Netherlands· NL-95bba0202119

Strepfen Citroen & Honing 8,75 mg, zuigtabletten

A flurbiprofen product containing flurbiprofen, registered in Netherlands by Reckitt Benckiser Healthcare B.V.. The same ATC class is registered in 10 of our 19 countries.

ATC R02AX01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about flurbiprofenAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Flurbiprofen is registered in 10 of 19 countries.

Countries holding a registration under ATC R02AX01 (flurbiprofen), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search flurbiprofen products by name

Flurbiprofen · ATC R02AX01

10 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: FLURBIPROFEN
Manufacturer: Reckitt Benckiser Healthcare B.V.
Country: Netherlands (NL)
ATC code: R02AX01
ATC class: Flurbiprofen
Defined daily dose: 44 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
101477

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under R02AX01

Flurbiprofen, as other registers publish it.

All flurbiprofen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/134e56e7-7565-4992-bc9a-949192dc3bed
GET /v1/drugs/134e56e7-7565-4992-bc9a-949192dc3bed?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Zuigtablet",
  "route": "Oromucosaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h101477_smpc.pdf",
  "strength": null,
  "atc_label": "Flurbiprofen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg101477",
  "excipients": [
    "BUTYLHYDROXYANISOL (E 320)",
    "CITROENSMAAKSTOF",
    "GLUCOSE, VLOEIBAAR",
    "HONING",
    "KALIUMHYDROXIDE (E 525)",
    "LEVOMENTHOL",
    "MACROGOL 300",
    "SACCHAROSE",
    "TARWEZETMEEL",
    "ZWAVELDIOXIDE (E 220)"
  ],
  "substances": [
    "FLURBIPROFEN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h101477.pdf",
  "authorised_at": "2010/09/15",
  "procedure_number": "NL/H/4456/001",
  "dispensing_status": "Uitsluitend apotheek of drogist$SEMICOLON$ Algemene verkoop Naar aanleiding van een additionele beoordeling",
  "registration_number": "101477",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about flurbiprofen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console